92 related articles for article (PubMed ID: 22320958)
41. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
42. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
43. Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.
Righi L; Volante M; Rapa I; Tavaglione V; Inzani F; Pelosi G; Papotti M
Endocr Relat Cancer; 2010 Dec; 17(4):977-87. PubMed ID: 20817788
[TBL] [Abstract][Full Text] [Related]
44. Practical problems of measuring depth of submucosal invasion in T1 colorectal carcinomas.
Kouyama Y; Kudo SE; Miyachi H; Ichimasa K; Hisayuki T; Oikawa H; Matsudaira S; Kimura YJ; Misawa M; Mori Y; Kodama K; Kudo T; Hayashi T; Wakamura K; Katagiri A; Hidaka E; Ishida F; Hamatani S
Int J Colorectal Dis; 2016 Jan; 31(1):137-46. PubMed ID: 26428364
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma.
Sanjuán X; Fernández PL; Miquel R; Muñoz J; Castronovo V; Ménard S; Palacín A; Cardesa A; Campo E
J Pathol; 1996 Aug; 179(4):376-80. PubMed ID: 8869283
[TBL] [Abstract][Full Text] [Related]
46. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
47. Colorectal tumors: the histology report.
Lanza G; Messerini L; Gafà R; Risio M; ;
Dig Liver Dis; 2011 Mar; 43 Suppl 4():S344-55. PubMed ID: 21459340
[TBL] [Abstract][Full Text] [Related]
48. Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer.
Cai Z; Ke J; He X; Yuan R; Chen Y; Wu X; Wang L; Wang J; Lan P; Wu X
Ann Surg Oncol; 2014 Jan; 21(1):179-88. PubMed ID: 23907312
[TBL] [Abstract][Full Text] [Related]
49. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH
Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050
[TBL] [Abstract][Full Text] [Related]
50. Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer.
Derwinger K; Kodeda K; Bexe-Lindskog E; Taflin H
Acta Oncol; 2010; 49(1):57-62. PubMed ID: 20001500
[TBL] [Abstract][Full Text] [Related]
51. [Association of 5-lipoxygenase expression and clinicopathological factors in colorectal carcinoma].
Li YC; Wang DX; Li CS; Ye ZP; Wu ZM; Chen JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):895-7. PubMed ID: 24062003
[TBL] [Abstract][Full Text] [Related]
52. The Expression and Significance of CXCR5 and MMP-13 in Colorectal Cancer.
Yan Q; Yuan Y; Yankui L; Jingjie F; Linfang J; Yong P; Dong H; Xiaowei Q
Cell Biochem Biophys; 2015 Sep; 73(1):253-9. PubMed ID: 25726157
[TBL] [Abstract][Full Text] [Related]
53. Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma.
Monteiro LS; Delgado ML; Ricardo S; Garcez F; do Amaral B; Warnakulasuriya S; Lopes C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 May; 115(5):638-45. PubMed ID: 23601218
[TBL] [Abstract][Full Text] [Related]
54. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
[TBL] [Abstract][Full Text] [Related]
55. Immunohistochemical characterization of the mTOR pathway in stage-I non-small-cell lung carcinoma.
Shin E; Choi CM; Kim HR; Jang SJ; Park YS
Lung Cancer; 2015 Jul; 89(1):13-8. PubMed ID: 25936472
[TBL] [Abstract][Full Text] [Related]
56. [Expression and correlational research of mTOR and 4EBP1 in laryngeal carcinoma].
Zhang X; Ba Y; Song R
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Dec; 26(23):1077-9, 1082. PubMed ID: 23451476
[TBL] [Abstract][Full Text] [Related]
57. Loss of SIRT1 histone deacetylase expression associates with tumour progression in colorectal adenocarcinoma.
Jang SH; Min KW; Paik SS; Jang KS
J Clin Pathol; 2012 Aug; 65(8):735-9. PubMed ID: 22554968
[TBL] [Abstract][Full Text] [Related]
58. Tissue expression of glycated apolipoprotein B in colorectal adenoma and cancer.
Reddavide R; Misciagna G; Caruso MG; Notarnicola M; Armentano R; Caruso ML; Pirrelli M; Valentini AM
Anticancer Res; 2011 Feb; 31(2):555-9. PubMed ID: 21378338
[TBL] [Abstract][Full Text] [Related]
59. Variation in MT expression in early-stage depressed-type and polypoid-type colorectal tumours.
Kuroda K; Aoyama N; Tamura T; Sakashita M; Maekawa S; Inoue T; Wambura C; Shirasaka D; Minami R; Maeda S; Kuroda Y; Kasuga M
Eur J Cancer; 2002 Sep; 38(14):1879-87. PubMed ID: 12204670
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological significance and prognostic value of LRP16 expression in colorectal carcinoma.
Xi HQ; Zhao P; Han WD
World J Gastroenterol; 2010 Apr; 16(13):1644-8. PubMed ID: 20355243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
